Changes in Mitral Annular Geometry and Dynamics With &bgr;-Blockade in Patients With Degenerative Mitral Valve Disease

Background—Remodeling of the mitral annulus contributes to progression of mitral regurgitation (MR). In patients with moderate-to-severe MR, short-term treatment with &bgr;-blockers has been shown to increase left ventricular (LV) end-diastolic and end-systolic volume, and this could deleteriously increase mitral valve annular dimensions. The objective of this study was to quantify the effects of a short duration of &bgr;-blocker treatment on mitral annular dimensions and dynamics in patients with MR due to primary degenerative valve disease. Methods and Results—Twenty-five patients with moderate-to-severe degenerative MR and normal LV systolic function were studied in a double-blind crossover experiment using a &bgr;1-selective adrenergic blocker and placebo administered for 14±3 days. Cardiac MRI images were acquired after each treatment period to quantify mitral annular dimensions. At end diastole, there was no change in annular area (1659±331 versus 1632±299 mm2; P<0.19), annular perimeter (154.3±16.4 versus 152±13.9 mm; P<0.13), septal-lateral (SL) dimension (38.0±5 versus 39.0±4.5 mm; P<0.15), or annular height (9.8±3.8 versus 9.5±2.5 mm; P<0.53). &bgr;-blockade resulted in significant end-diastole decreases in commissure-commissure dimension (48.9±4.6 versus 47.2±4.0 mm; P<0.01) and eccentricity (1.3±0.2 versus 1.2±0.1; P<0.01). At end systole (ES), &bgr;-blockade conferred a small, but significant decrease in annular perimeter (161.0±19.3 versus 156.8±16.9 mm; P<0.04) and eccentricity (1.2±0.1 versus 1.1±0.1; P<0.02), and the SL dimension significantly increased (41.5±5.7 versus 43.0±5.3 mm; P<0.03). Commissure-commissure dimension, annular area, and annular height at ES were not significantly different. Conclusions—Despite significant increases in LV end-diastolic and end-systolic volume, short-term &bgr;-blocker treatment of patients with moderate-to-severe MR reduced or preserved all mitral annular dimensions except SL at ES.

[1]  Thoralf M. Sundt,et al.  Early surgery is recommended for mitral regurgitation. , 2010, Circulation.

[2]  L. Gillam,et al.  Primum non nocere: the case for watchful waiting in asymptomatic "severe" degenerative mitral regurgitation. , 2010, Circulation.

[3]  Jeroen J. Bax,et al.  MRI to Evaluate Left Atrial and Ventricular Reverse Remodeling After Restrictive Mitral Annuloplasty in Dilated Cardiomyopathy , 2005, Circulation.

[4]  Robert C Gorman,et al.  The effect of regional ischemia on mitral valve annular saddle shape. , 2004, The Annals of thoracic surgery.

[5]  Bo Li,et al.  GPU Accelerated Non-rigid Registration for the Evaluation of Cardiac Function , 2008, MICCAI.

[6]  L. Gillam,et al.  Is early surgery recommended for mitral regurgitation? , 2010 .

[7]  Joseph H. Gorman,et al.  Three-dimensional echocardiographic assessment of changes in mitral valve geometry after valve repair. , 2009, The Annals of thoracic surgery.

[8]  D. Ennis,et al.  The effect of pure mitral regurgitation on mitral annular geometry and three-dimensional saddle shape. , 2008, The Journal of thoracic and cardiovascular surgery.

[9]  B. Cowan,et al.  Pilot Study to Assess the Influence of &bgr;-Blockade on Mitral Regurgitant Volume and Left Ventricular Work in Degenerative Mitral Valve Disease , 2008, Circulation.

[10]  Giuseppe Saracino,et al.  Local Dysfunction and Asymmetrical Deformation of Mitral Annular Geometry in Ischemic Mitral Regurgitation: A Novel Computerized 3D Echocardiographic Analysis , 2008, Echocardiography.

[11]  D. Altman,et al.  STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT , 1986, The Lancet.

[12]  Douglas W Mahoney,et al.  Mitral Annular Dynamics in Myxomatous Valve Disease: New Insights With Real-Time 3-Dimensional Echocardiography , 2010, Circulation.

[13]  A A Young,et al.  Three-dimensional changes in left and right ventricular geometry in chronic mitral regurgitation. , 1996, The American journal of physiology.

[14]  David Liang,et al.  Annular remodeling in chronic ischemic mitral regurgitation: ring selection implications. , 2003, The Annals of thoracic surgery.

[15]  P. Varadarajan,et al.  Effect of Beta-blocker therapy on survival in patients with severe mitral regurgitation and normal left ventricular ejection fraction. , 2008, The American journal of cardiology.

[16]  B. Carabello,et al.  Differential effects of the angiotensin-converting enzyme inhibitor lisinopril versus the beta-adrenergic receptor blocker atenolol on hemodynamics and left ventricular contractile function in experimental mitral regurgitation. , 2002, Journal of the American College of Cardiology.